Dietary Protein Intake, Inflammatory Biomarkers, Genetic Susceptibility, and the Incidence of Sarcopenia: A Prospective Population-Based Study

Why It Matters

The results highlight plant‑based protein as a modifiable factor that can modestly lower sarcopenia risk, especially for individuals with high genetic susceptibility, informing nutrition guidance for aging populations.

Key Takeaways

• Plant protein intake reduces sarcopenia risk by 25% in highest quartile
• Inflammatory markers mediate about ten percent of plant protein’s effect
• High genetic risk raises sarcopenia odds; plant protein lowers it modestly
• Total and animal protein show no significant link after full adjustment
• Protective effect strongest among women and adults under 65

Pulse Analysis

Sarcopenia, the age‑related loss of muscle mass and strength, drives falls, hospitalizations, and mortality among older adults. With no approved pharmacologic cure, nutrition remains a primary preventive lever. Protein is essential for muscle protein synthesis, yet epidemiologic data have been mixed, partly because most studies rely on small, cross‑sectional samples and fail to differentiate protein sources. The rise of large biobanks now enables researchers to examine long‑term dietary patterns alongside genetic and inflammatory markers, offering a more nuanced view of how diet influences muscle health.

The UK Biobank analysis of 37,870 white European participants followed for an average of 11.5 years found that higher plant‑based protein intake was linked to a 25 % lower hazard of incident sarcopenia, while total and animal protein showed no independent benefit after comprehensive adjustment. Mediation modeling indicated that C‑reactive protein, white‑blood‑cell, monocyte and platelet counts together explained roughly ten percent of the protective association, suggesting that anti‑inflammatory compounds in plant foods play a role. Moreover, individuals with a high sarcopenia polygenic risk score experienced a six‑fold increase in risk, yet those with higher plant protein intake within this high‑risk group reduced their hazard by about 40 %.

These findings reinforce the growing consensus that plant‑rich diets can support musculoskeletal health beyond traditional nutrient metrics. Clinicians advising older patients may consider emphasizing legumes, nuts, seeds and whole‑grain proteins to achieve at least the upper range of recommended intake, especially for women and those under 65 where effects appeared strongest. The modest mediation by inflammation also highlights the potential of combined dietary‑and‑lifestyle strategies, such as anti‑oxidant‑rich foods and regular exercise, to attenuate sarcopenia risk. Future trials should test whether targeted plant‑protein interventions can offset genetic susceptibility and translate into functional improvements in real‑world settings.